Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33014, Tampere, Finland.
Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland.
Stem Cell Res Ther. 2021 Sep 26;12(1):516. doi: 10.1186/s13287-021-02587-0.
Adipose stromal/stem cells (ASCs) are promising candidates for future clinical applications. ASCs have regenerative capacity, low immunogenicity, and immunomodulatory ability. The success of future cell-based therapies depends on the appropriate selection of donors. Several factors, including age, sex, and body mass index (BMI), may influence ASC characteristics. Our aim was to investigate the effect of acquired weight on ASC characteristics under the same genetic background using ASCs derived from monozygotic (MZ) twin pairs.
ASCs were isolated from subcutaneous adipose tissue from five weight-discordant (WD, within-pair difference in BMI > 3 kg/m) MZ twin pairs, with measured BMI and metabolic status. The ASC immunophenotype, proliferation and osteogenic and adipogenic differentiation capacity were studied. ASC immunogenicity, immunosuppression capacity and the expression of inflammation markers were investigated. ASC angiogenic potential was assessed in cocultures with endothelial cells.
ASCs showed low immunogenicity, proliferation, and osteogenic differentiation capacity independent of weight among all donors. ASCs showed a mesenchymal stem cell-like immunophenotype; however, the expression of CD146 was significantly higher in leaner WD twins than in heavier cotwins. ASCs from heavier twins from WD pairs showed significantly greater adipogenic differentiation capacity and higher expression of TNF and lower angiogenic potential compared with their leaner cotwins. ASCs showed immunosuppressive capacity in direct cocultures; however, heavier WD twins showed stronger immunosuppressive capacity than leaner cotwins.
Our genetically matched data suggest that a higher weight of the donor may have some effect on ASC characteristics, especially on angiogenic and adipogenic potential, which should be considered when ASCs are used clinically.
脂肪基质/干 细胞(ASCs)是未来临床应用的有前途的候选者。ASCs 具有再生能力、低免疫原性和免疫调节能力。未来细胞治疗的成功取决于供体的适当选择。一些因素,包括年龄、性别和体重指数(BMI),可能会影响 ASC 的特征。我们的目的是在相同的遗传背景下,使用来自同卵(MZ)双胞胎的 ASC 研究获得性体重对 ASC 特征的影响。
从五对体重不同(WD,BMI 差异>3kg/m)的 MZ 双胞胎的皮下脂肪组织中分离 ASC,测量 BMI 和代谢状态。研究 ASC 免疫表型、增殖能力以及成骨和成脂分化能力。研究 ASC 免疫原性、免疫抑制能力和炎症标志物的表达。通过与内皮细胞共培养评估 ASC 的血管生成潜力。
所有供体的 ASC 均表现出低免疫原性、增殖和成骨分化能力,而与体重无关。ASC 表现出间充质干细胞样免疫表型;然而,较瘦的 WD 双胞胎中的 CD146 表达明显高于较胖的同卵双胞胎。来自 WD 对体重较重的双胞胎的 ASC 表现出更强的成脂分化能力和更高的 TNF 表达以及较低的血管生成潜力,而与其较瘦的同卵双胞胎相比。ASC 在直接共培养中表现出免疫抑制能力;然而,体重较重的 WD 双胞胎表现出比较瘦的同卵双胞胎更强的免疫抑制能力。
我们的基因匹配数据表明,供体的体重较高可能对 ASC 特征产生一些影响,尤其是对血管生成和脂肪生成潜力的影响,在临床应用 ASC 时应考虑这些因素。